Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

STAT-Diagnostica Appoints Board Chairman

Published: Thursday, June 20, 2013
Last Updated: Thursday, June 20, 2013
Bookmark and Share
Company names Gérard Vaillant as chairman of the company’s board of directors.

STAT-Diagnostica has appointed Gérard Vaillant as chairman of the company’s board of directors. With more than three decades of senior leadership experience in the medical device and diagnostics sector, he brings expert industry perspective and guidance to the company as it prepares for the successive European and U.S. launches of its novel DiagCORE Near Patient Testing platform.

Vaillant is a career veteran of Johnson & Johnson Worldwide who has held of number of senior executive positions within the organization.

These include managing director, Ortho Clinical Diagnostics France (1981 - 1987); vice president, Johnson & Johnson International (1987 - 1992); worldwide president, LifeScan, a Johnson & Johnson company (1992 - 1995); and company group chairman, Diagnostics Worldwide (1995 - 2004).

He was also a member of Johnson & Johnson’s Medical Devices and Diagnostic Group Operating Committee until retiring in 2004.

After his retirement from Johnson & Johnson, he remained active in the industry as board member of both Luminex and Vivacta.

In addition to his current position with STAT-Diagnostica, Vaillant currently serves as chairman of the board of SafeOrthopaedics and PathoQuest; board member of Tecan CH; and venture partner at KLS Partners.

“We are very privileged to have Gérard join as the chairman of our board of directors,” said Jordi Carrerra, CEO and co-founder of STAT-Diagnostica.

Carrerra continued, “His deep industry pedigree and proven track record of success will be invaluable to us as we move towards European and U.S. approval and commercialization of our DiagCORE platform.”

Vaillant joins STAT-Diagnostica following the company’s closing of a Series B financing round totaling $22.1 million/17 million Euros, which was announced May 6, 2013.

Led by new investor Kurma Life Sciences Partners, the round also drew participation from new investors Idinvest; Boehringer Ingelheim Venture Fund; and, Caixa Capital Risc, the venture capital division of “la Caixa;” as well as existing investors Ysios Capital and Axis.

The proceeds of the funding are being used to complete development of the company’s DiagCORE platform and clinical validation of its first products.

“The DiagCORE platform represents a significant breakthrough in the area of Near Patient Testing that stands to change clinical practice in the critical care setting,” said Vaillant.

Vaillant continued, “In addition to its unique technology, STAT-Diagnostica’s excellent leadership and strong investor support are what attracted me to the board chairman position. I look forward to being part of the company’s future success.”

STAT-Diagnostica’s DiagCORE Near Patient Testing platform is designed to simplify and reduce time to results for the diagnosis of certain medical conditions.

The in vitro diagnostic system is a versatile, easy-to-use platform that consolidates molecular and immunoassay techniques in a single device.

The first clinical applications will be directed at infectious disease detection, antibiotic resistance determination and detection of biomarkers in critically ill patients.

STAT-Diagnostica’s DiagCORE platform not only offers multi-analyte and multi-sample capabilities, but it also reduces current diagnosis times (which can take up to several days) by providing results in less than 30 minutes.

The system’s rapid performance will enable improved clinical decision making by medical practitioners, delivering better patient management with direct and indirect savings to the healthcare system.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Proteins in Blood of Heart Disease Patients May Predict Adverse Events
Nine-protein test shown superior to conventional assessments of risk.
£14m EU Project To Aid Meningitis Diagnosis and Cut Antibiotic Use
An international team of doctors are aiming to develop a rapid test to allow medics to quickly identify bacterial infection in children.
Bringing AFM to Medical Diagnostics
Company has announced that its NanoWizard® AFM and ForceRobot® systems are being used in the field of medical diagnostics in the Supersensitive Molecular Layer Laboratory of POSTECH in Korea.
Scientific Gains May Make Electronic Nose the Next Everyday Device
UT Dallas team breathes new life into possibilities by using CMOS integrated circuits technology.
Electronic Sensor Tells Dead Bacteria From Live
The sensor, which measures 'osmoregulation', is a potential future tool for medicine and food safety.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
A Future Tool for Medicine, Food Safety
A new type of electronic sensor that might be used to quickly detect and classify bacteria for medical diagnostics and food safety has passed a key hurdle by distinguishing between dead and living bacteria cells.
Genome Sequencing Helps Determine End of TB Outbreak
Using genome sequencing, researchers from the University of British Columbia, along with colleagues at the Imperial College in London, now have the ability to determine when a tuberculosis (TB) outbreak is over.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Shimmer Partners with Harvard's Wyss Institute
Partnership to support ongoing research focused on remote patient monitoring using wearable sensing technology.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!